Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Align Technology Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Align Technology Inc. May 21, 202588.2%
-
Align Technology Inc. May 16, 202486.1%
-
Align Technology Inc. May 17, 202384.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 3, 2026 | Neurocrine Biosciences Inc. | Option exercise | +7,200 | $53.64 | $386,208 |
| Nov 3, 2026 | Neurocrine Biosciences Inc. | Open-market sale | −100 | $158.18 | $15,818 |
| Nov 3, 2026 | Neurocrine Biosciences Inc. | Open-market sale | −100 | $162.05 | $16,205 |
| Nov 3, 2026 | Neurocrine Biosciences Inc. | Open-market sale | −600 | $163.71 | $98,225 |
| Nov 3, 2026 | Neurocrine Biosciences Inc. | Open-market sale | −1,226 | $164.74 | $201,971 |
| Nov 3, 2026 | Neurocrine Biosciences Inc. | Open-market sale | −908 | $165.71 | $150,461 |
| Nov 3, 2026 | Neurocrine Biosciences Inc. | Open-market sale | −1,466 | $166.77 | $244,492 |
| Nov 3, 2026 | Neurocrine Biosciences Inc. | Open-market sale | −1,500 | $167.72 | $251,587 |
| Nov 3, 2026 | Neurocrine Biosciences Inc. | Open-market sale | −1,300 | $168.53 | $219,092 |
| Nov 2, 2026 | Neurocrine Biosciences Inc. | Option exercise | +7,500 | $53.64 | $402,300 |
| Nov 2, 2026 | Neurocrine Biosciences Inc. | Open-market sale | −1,900 | $144.98 | $275,453 |
| Nov 2, 2026 | Neurocrine Biosciences Inc. | Open-market sale | −4,300 | $145.86 | $627,194 |
| Nov 2, 2026 | Neurocrine Biosciences Inc. | Open-market sale | −1,300 | $146.76 | $190,783 |
| Oct 30, 2026 | Neurocrine Biosciences Inc. | Option exercise | +300 | $53.64 | $16,092 |
| Oct 30, 2026 | Neurocrine Biosciences Inc. | Open-market sale | −300 | $149.00 | $44,700 |
Questions about George J. Morrow
What boards is George J. Morrow on?
George J. Morrow sits on the boards of Align Technology Inc. and Neurocrine Biosciences Inc.
How long has George J. Morrow served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.